NasdaqCM:SRTS

Stock Analysis Report

Executive Summary

Sensus Healthcare, Inc. manufactures and markets superficial radiation therapy devices to healthcare providers worldwide.

Snowflake

Fundamentals

Excellent balance sheet with high growth potential.


Similar Companies

Share Price & News

How has Sensus Healthcare's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0%

NasdaqCM:SRTS

-0.9%

US Medical Equipment

1.3%

US Market


1 Year Return

-6.3%

NasdaqCM:SRTS

9.1%

US Medical Equipment

2.0%

US Market

SRTS underperformed the Medical Equipment industry which returned 8.7% over the past year.

SRTS underperformed the Market in United States of America which returned 1.7% over the past year.


Share holder returns

SRTSIndustryMarket
7 Day0%-0.9%1.3%
30 Day0.2%0.7%3.9%
90 Day19.7%4.4%3.4%
1 Year-6.3%-6.3%10.0%9.1%4.2%2.0%
3 Year1.9%1.9%70.7%65.5%47.2%37.6%
5 Yearn/a130.7%104.3%60.5%42.9%

Price Volatility Vs. Market

How volatile is Sensus Healthcare's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Sensus Healthcare undervalued based on future cash flows and its price relative to the stock market?

>50%

Discount to future cash flow value


Intrinsic Value Based on Future Cash Flows

Sensus Healthcare's share price is below the future cash flow value, and at a moderate discount (> 20%).

Sensus Healthcare's share price is below the future cash flow value, and at a substantial discount (> 40%).


Price Based on Earnings

Sensus Healthcare is loss making, we can't compare its value to the US Medical Equipment industry average.

Sensus Healthcare is loss making, we can't compare the value of its earnings to the United States of America market.


Price Based on Expected Growth

Unable to calculate PEG ratio for Sensus Healthcare, we can't assess if its growth is good value.


Price Based on Value of Assets

Sensus Healthcare is good value based on assets compared to the US Medical Equipment industry average.


Next Steps

Future Growth

How is Sensus Healthcare expected to perform in the next 1 to 3 years based on estimates from 7 analysts?

120.3%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

Sensus Healthcare's revenue is expected to grow significantly at over 20% yearly.

Sensus Healthcare's earnings are expected to grow significantly at over 20% yearly.

Sensus Healthcare's revenue growth is expected to exceed the United States of America market average.

Sensus Healthcare's earnings growth is expected to exceed the United States of America market average.

Sensus Healthcare's earnings growth is expected to exceed the low risk savings rate of 2.7%.


Earnings per Share Growth Estimates


Future Return on Equity

Unable to establish if Sensus Healthcare will efficiently use shareholders’ funds in the future without estimates of Return on Equity.


Next Steps

Past Performance

How has Sensus Healthcare performed over the past 5 years?

-14.6%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Sensus Healthcare does not make a profit and their year on year earnings growth rate was negative over the past 5 years.

Unable to compare Sensus Healthcare's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare Sensus Healthcare's 1-year growth to the US Medical Equipment industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if Sensus Healthcare has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.


Return on Assets

It is difficult to establish if Sensus Healthcare has efficiently used its assets last year compared to the US Medical Equipment industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if Sensus Healthcare improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.


Next Steps

Financial Health

How is Sensus Healthcare's financial position?


Financial Position Analysis

Sensus Healthcare is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

Sensus Healthcare's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

Sensus Healthcare's level of debt (0%) compared to net worth is satisfactory (less than 40%).

The level of debt compared to net worth has been reduced over the past 5 years (6.2% vs 0% today).


Balance Sheet

Low level of unsold assets.

Debt is not covered by short term assets, assets are -1.4796746811792E+17x debt.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Sensus Healthcare has sufficient cash runway for more than 3 years based on current free cash flow.

Unable to confirm if Sensus Healthcare has at least 1 year of cash runway based on growing free cash flows without relevant data.


Next Steps

Dividend

What is Sensus Healthcare's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Sensus Healthcare's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Sensus Healthcare's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Sensus Healthcare has not reported any payouts.

Unable to verify if Sensus Healthcare's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Sensus Healthcare has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Sensus Healthcare's salary, the management and board of directors tenure and is there insider trading?

9.3yrs

Average management tenure


CEO

Joe Sardano (66yo)

9.3yrs

Tenure

US$538,392

Compensation

Mr. Joseph C. Sardano, also known as Joe, has been the Chairman of the Board, Chief Executive Officer and President of Sensus Healthcare, Inc. since June 2010. Mr. Sardano, A recognized leader in the heal ...


CEO Compensation Analysis

Joe's remuneration is about average for companies of similar size in United States of America.

Joe's compensation has increased whilst company is loss making.


Management Age and Tenure

9.3yrs

Average Tenure

61yo

Average Age

The average tenure for the Sensus Healthcare management team is over 5 years, this suggests they are a seasoned and experienced team.


Board Age and Tenure

7.6yrs

Average Tenure

70yo

Average Age

The tenure for the Sensus Healthcare board of directors is about average.


Insider Trading

No 3 month open market individual insider trading information.


Ownership Breakdown


Management Team

  • Clay Cockerell (62yo)

    Medical Director & Member of Medical Advisory Board

    • Tenure: 0yrs
  • Joe Sardano (66yo)

    Chairman

    • Tenure: 9.3yrs
    • Compensation: US$538.39k
  • Arthur Levine (61yo)

    Chief Financial Officer

    • Tenure: 5.1yrs
    • Compensation: US$584.60k
  • Kal Fishman (48yo)

    COO & Chief Technology Officer

    • Tenure: 9.3yrs
    • Compensation: US$361.74k
  • Richard Golin (65yo)

    Executive Vice President of International Sales

    • Tenure: 9.3yrs
  • Steve Cohen (59yo)

    Executive Vice President of Strategic Initiatives & Dermatology Sales

    • Tenure: 9.3yrs
    • Compensation: US$478.62k
  • Mark Nestor

    Clinical Director & Member of Medical Advisory Board

    • Tenure: 6.1yrs
  • Michael Sardano (30yo)

    VP, General Counsel

    • Tenure: 2.7yrs

Board Members

  • Clay Cockerell (62yo)

    Medical Director & Member of Medical Advisory Board

    • Tenure: 0yrs
  • Joe Sardano (66yo)

    Chairman

    • Tenure: 9.3yrs
    • Compensation: US$538.39k
  • Armand Cognetta

    Chairman of Medical Advisory Board

    • Tenure: 8.6yrs
  • John Heinrich (71yo)

    Independent Director

    • Tenure: 7.6yrs
    • Compensation: US$171.00k
  • Sam O'Rear (70yo)

    Independent Director

    • Tenure: 7.6yrs
    • Compensation: US$171.00k
  • Gary Monheit

    Member of Medical Advisory Board

    • Tenure: 0yrs
  • Angela Abbatecola

    Member of Medical Advisory Board

    • Tenure: 0yrs
  • Mark Nestor

    Clinical Director & Member of Medical Advisory Board

    • Tenure: 6.1yrs
  • Bill McCall (72yo)

    Independent Non-Executive Director

    • Tenure: 3.9yrs
    • Compensation: US$171.00k
  • William Roth

    Member of Medical Advisory Board

    • Tenure: 0yrs

Company Information

Sensus Healthcare, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Sensus Healthcare, Inc.
  • Ticker: SRTS
  • Exchange: NasdaqCM
  • Founded: 2010
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: US$105.086m
  • Shares outstanding: 16.50m
  • Website: https://www.sensushealthcare.com

Number of Employees


Location

  • Sensus Healthcare, Inc.
  • 851 Broken Sound Parkway NW
  • Suite 215
  • Boca Raton
  • Florida
  • 33487
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
SRTSNasdaqCM (Nasdaq Capital Market)YesCommon StockUSUSDJul 2016

Biography

Sensus Healthcare, Inc. manufactures and markets superficial radiation therapy devices to healthcare providers worldwide. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that p ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/16 00:25
End of Day Share Price2019/09/13 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.